The SLC22A18 gene helps cells control growth and activity, especially during early development. This gene plays an important role in keeping growth more balanced, so variants that reduce its function may contribute to unusual growth patterns and may be linked with some cancers. It sits in an imprinted chromosome region, which means the copy from one parent is mainly used. Changes in this same region are also associated with Beckwith-Wiedemann syndrome, a condition that affects growth.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. To look into this subject more closely, you can find more information in LearnHub.
Overview
SLC22A18Gene function
What if the gene works
The SLC22A18 gene likely helps move certain small molecules across cell membranes. This supports normal cell activity and may play a part in growth and development.
Risk
What if the gene does not work
Milder to more severe variants in the SLC22A18 gene can reduce or disrupt the SLC22A18 protein, which is thought to help move small molecules across cell membranes and support normal control of cell growth.
Treatment
What does that mean for your treatment
No SLC22A18-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the SLC22A18 gene. The SLC22A18 gene is being studied as a possible biomarker in some cancers, but this has not led to routine, gene-directed drug choices.
Conditions associated with SLC22A18
Gene function
What if the gene works
Many cells rely on a steady flow of small molecules across their outer membrane. The SLC22A18 gene supports this everyday transport. Understanding the SLC22A18 gene's role in cell transport helps show how cells maintain routine chemical balance.
This protein sits in the cell membrane and supports the movement of certain small charged molecules. That flow helps cells exchange compounds with their surroundings in a controlled way.
By regulating this everyday traffic, its protein helps cells keep a stable internal environment. This steady exchange supports routine cell work, including taking in useful compounds and moving others back out.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and help explain normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC22A18 gene can reduce how much protein a cell makes, change how the protein folds, or keep it from reaching the cell membrane, which helps explain how SLC22A18 gene variants affect cell function. Some changes may also disturb imprinting (the parent-specific control of gene activity). Milder variants may leave some activity, while more disruptive variants can greatly reduce protein stability or stop production of a full-length protein.
How variants are linked to conditions
Variants of the SLC22A18 gene are still being studied, and the SLC22A18 gene has not yet been tied to a single, broadly confirmed inherited condition. Research on how SLC22A18 gene variants are linked to conditions is still evolving, so anyone with a confirmed finding in this gene should rely on guidance from their doctor or genetic counselor.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely found in the general population. Most have no direct impact on health and simply reflect natural variation between people. For many genes, carrying a variant tied to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC22A18 gene. If a change in SLC22A18 is found on genetic testing, a doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
Inheritance of SLC22A18 variants
There is not yet a broadly confirmed, disease-specific Mendelian inheritance pattern for the SLC22A18 gene that is used in routine clinical genetics. In practice, how SLC22A18 gene variants are inherited is not described as a single clear pattern such as autosomal dominant or autosomal recessive. The SLC22A18 gene is located on chromosome 11, which is an autosome, so you inherit one copy from each parent. This region also has parent-of-origin effects in some situations, which means the impact of a variant can depend on whether it came from the mother or the father.
What does my SLC22A18 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for SLC22A18, and this area is still being studied. If you have a specific SLC22A18 result, what it means for relatives depends on the exact change and the health condition being considered. A genetics specialist can help explain whether family members might also want to review their results.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SLC22A18 gene usually uses a blood or saliva sample. SLC22A18 genetic testing reads the gene's DNA sequence, and sometimes checks for missing or extra pieces, to see whether a variant is present. Results may show a known variant, no variant found, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established reason to get genetic testing just for the SLC22A18 gene. Decisions about testing are usually based on your own health history, family history, and guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic findings can offer valuable insight, but how much they explain depends on the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than another. This is common and can influence how much benefit someone gets or how likely they are to have side effects.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes affect the way a person responds to medication. It examines gene and drug patterns to help explain why the same treatment can work differently in different people. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help support better informed, more individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the SLC22A18 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding medication response. For concerns about side effects, medicine interactions, or whether a treatment is a good fit for you, speak with your doctor or pharmacist.
History
SLC22A18 came into focus in the 1990s, when researchers were closely studying the 11p15.5 chromosome region because of its links to inherited growth conditions and some cancers. It was identified as an imprinted gene, meaning the copy inherited from one parent is more active than the other, which made it especially important in early work on parent-of-origin effects in human genetics. Initially understood only through visible traits, later recognized as tied to a specific gene, this region helped scientists connect unusual growth patterns with altered gene activity. From these first observations, research expanded steadily. Over time, SLC22A18 was also investigated for a possible role in tumor suppression, adding to its place in the history of cancer genetics and genomic imprinting research.